Related Experiment Video

Updated: Jul 31, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

AMPD1 C34T mutation selectively affects AMP-deaminase activity in the human heart

K K Kalsi1, A H Y Yuen, P H Johnson

  • 1Heart Science Centre, Imperial College at Harefield Hospital, Harefield, Middlesex, UK. K.Kalsi@imperial.ac.uk

Nucleosides, Nucleotides & Nucleic Acids
|July 19, 2005
PubMed

Insights

A specific gene mutation (AMPD1 C34T) may improve heart failure survival by altering cardiac metabolism. This nonsense mutation reduces AMP-deaminase activity in the heart, potentially via local metabolic changes.

Area of Science:

  • Biochemistry
  • Cardiovascular Medicine
  • Genetics

Background:

  • The AMPD1 C34T gene mutation is associated with enhanced survival in heart failure patients.
  • This mutation is understood to reduce AMP-deaminase activity in skeletal muscle.
  • Adenosine formation is a potential mechanism linked to the protective effects of this mutation.

Purpose of the Study:

  • To investigate the effect of the AMPD1 C34T mutation on AMP-deaminase activity within the heart.
  • To determine if this mutation impacts other enzymes involved in adenine nucleotide metabolism in cardiac tissue.
  • To explore the potential role of localized cardiac metabolic alterations in the mutation's protective mechanism.

Main Methods:

  • Enzyme activity assays were performed on cardiac tissue samples.
  • Specific focus on AMP-deaminase activity.
  • Analysis included other key enzymes in the adenine nucleotide metabolic pathway.

Main Results:

  • The AMPD1 C34T mutation was confirmed to decrease AMP-deaminase activity in the heart.
  • No significant changes were observed in the activity of other adenine nucleotide metabolism enzymes.
  • Findings suggest a specific impact on cardiac AMP-deaminase.

Conclusions:

  • The AMPD1 C34T mutation induces local metabolic changes within the heart.
  • Reduced cardiac AMP-deaminase activity is a key consequence of this mutation.
  • These cardiac-specific metabolic alterations may underlie the observed protective effects in heart failure.

More Related Videos

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Related Concept Videos

Mutations01:39

Mutations

Overview
RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
ATP Synthase: Structure01:18

ATP Synthase: Structure

ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...